Reaction Details |
| Report a problem with these data |
Target | Phospholipase D2 |
---|
Ligand | BDBM247409 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Cell-Based Assay |
---|
IC50 | 20±n/a nM |
---|
Citation | Lindsley, CW; Brown, AH Antiviral therapies with phospholipase D inhibitors US Patent US9453017 Publication Date 9/27/2016 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Phospholipase D2 |
---|
Name: | Phospholipase D2 |
Synonyms: | PLD2 | PLD2_HUMAN | Phospholipase D2 | Phospholipase D2 (PLD2) | phospholipase D2 isoform PLD2A |
Type: | Protein |
Mol. Mass.: | 106002.47 |
Organism: | Homo sapiens (Human) |
Description: | n/a |
Residue: | 933 |
Sequence: | MTATPESLFPTGDELDSSQLQMESDEVDTLKEGEDPADRMHPFLAIYELQSLKVHPLVFA
PGVPVTAQVVGTERYTSGSKVGTCTLYSVRLTHGDFSWTTKKKYRHFQELHRDLLRHKVL
MSLLPLARFAVAYSPARDAGNREMPSLPRAGPEGSTRHAASKQKYLENYLNRLLTMSFYR
NYHAMTEFLEVSQLSFIPDLGRKGLEGMIRKRSGGHRVPGLTCCGRDQVCYRWSKRWLVV
KDSFLLYMCLETGAISFVQLFDPGFEVQVGKRSTEARHGVRIDTSHRSLILKCSSYRQAR
WWAQEITELAQGPGRDFLQLHRHDSYAPPRPGTLARWFVNGAGYFAAVADAILRAQEEIF
ITDWWLSPEVYLKRPAHSDDWRLDIMLKRKAEEGVRVSILLFKEVELALGINSGYSKRAL
MLLHPNIKVMRHPDQVTLWAHHEKLLVVDQVVAFLGGLDLAYGRWDDLHYRLTDLGDSSE
SAASQPPTPRPDSPATPDLSHNQFFWLGKDYSNLITKDWVQLDRPFEDFIDRETTPRMPW
RDVGVVVHGLPARDLARHFIQRWNFTKTTKAKYKTPTYPYLLPKSTSTANQLPFTLPGGQ
CTTVQVLRSVDRWSAGTLENSILNAYLHTIRESQHFLYIENQFFISCSDGRTVLNKVGDE
IVDRILKAHKQGWCYRVYVLLPLLPGFEGDISTGGGNSIQAILHFTYRTLCRGEYSILHR
LKAAMGTAWRDYISICGLRTHGELGGHPVSELIYIHSKVLIADDRTVIIGSANINDRSLL
GKRDSELAVLIEDTETEPSLMNGAEYQAGRFALSLRKHCFGVILGANTRPDLDLRDPICD
DFFQLWQDMAESNANIYEQIFRCLPSNATRSLRTLREYVAVEPLATVSPPLARSELTQVQ
GHLVHFPLKFLEDESLLPPLGSKEGMIPLEVWT
|
|
|
BDBM247409 |
---|
n/a |
---|
Name | BDBM247409 |
Synonyms: | US9453017, 1 |
Type | Small organic molecule |
Emp. Form. | C26H27FN4O2 |
Mol. Mass. | 446.5166 |
SMILES | Fc1cccc(c1)N1C(=O)NCC11CCN(CCNC(=O)c2ccc3ccccc3c2)CC1 |
Structure |
|